Quantum Discovery Labs » drug design http://q-pharm.com The drug discovery company Fri, 02 Mar 2012 06:38:21 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/ http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/#comments Tue, 09 Aug 2011 06:18:11 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=419
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • Quantum Discovery Services
  • Beefing up the pipeline: new leads against influenza virus identified
  • From binding data to pharmacokinetics: a novel approach to active drug absorbtion prediction
  • Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.
    • ]]>     http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/feed/ 0     New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1 http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/ http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/#comments Tue, 21 Jun 2011 11:28:21 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=390
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • MA/p17 HIV matrix protein is a promising target for drug discovery
  • From Biological Spectra (multiple protein binding data) to pharmacological profiling!
  • Do we need those nM-inhibitors?
    • ]]>     http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/feed/ 0     Influenza matrix M1 protein inhibitors show promising in-vivo efficacy http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/ http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/#comments Sun, 10 Apr 2011 11:36:29 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=372
  • New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1
  • MA/p17 HIV matrix protein is a promising target for drug discovery
  • Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
  • Beefing up the pipeline: new leads against influenza virus identified
  • Do we need those nM-inhibitors?
    • ]]>     http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/feed/ 1     Beefing up the pipeline: new leads against influenza virus identified http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/ http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/#comments Mon, 20 Sep 2010 07:49:30 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=317
  • Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
  • Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo
  • New inhibitors of RecA (bacterial SOS response system) identified.
    • ]]>     http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/feed/ 0     New inhibitors of RecA (bacterial SOS response system) identified. http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/ http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/#comments Wed, 14 Jul 2010 07:29:11 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=306 http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/feed/ 2